In the last century, the discovery of cytotoxic agents was revolutionary for anticancer drug therapy. These anticancer drug therapies have resulted in better understanding of cancer in general. However, the development of agents that combine efficacy, safety and convenience remains a great challenge, due to the narrow, if not adverse, therapeutic index of most drugs, the fact that they may damage not only cancer cells, but also normal and healthy tissue and the occurrence of resistance, limiting anticancer efficacy. In this presentation, the development of promising novel cytotoxic solasodinerhamnosyl glycosides will be addressed that offer not only gains in specificity and efficacy, but also in safety, tolerability, non-resistance and convenience in the treatment of patients with cancer. (Bill E. Cham, Drug therapy: Solamargine and other solasodinerhamnosyl glycosides as anticancer agents)
A collaboration set up recently with 100 international societies would provide a window to wider knowledge-base of worldwide open access health-related information. As part of its drive to boost knowledge-sharing through real-time interaction, this open access group has been organizing over 100 world-class scientific conferences at global venues through the calendar year. Abstracts presented at the meets are invited from scholars with a track record of effective research papers that are also published as special journal issue for each of the conference. Apart from India and the US as established locations, the events would soon expand to several continents to add the regional touch through collaboration with scientific and healthcare bodies in respective geographies like Europe, Australia and the Middle East. Most of the international conferences comprise of day-long programs in the form of symposiums or workshops, which serve as a specialized program within the main event. Realizing the potential of open access in terms of greater visibility within and beyond the scientific community, in recent years, there has been a tremendous breakthrough to open access movement through various open access publishers. OMICS is one such publishing group that believes in this movement and is most ardently working towards the welfare and progress of scientific community.
Last date updated on July, 2014